CRP and metastatic malignant neoplasm in the lymph nodes: Similarly, Aktekin’s group (2019) reported significantly raised CRP levels in irresectable vs reseactable PDAC, as well as in patients with radiological lymph node metastasis compared to node negative disease [47].